Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 88 | 2,211,834,814 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
GILEAD SCIENCES INC | COM | 251 | $1,838,927 | 22,700 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
AEGLEA BIOTHERAPEUTICS INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
MERCK & CO INC | COM | 253 | $1,689,810 | 15,500 | 0.00 | 15,500 | +Inf | 12-31-2023 | |
MOLECULAR PARTNERS AG | ADS | 254 | $1,671,960 | 400,000 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |